PACAP (6-38), amide, human, ovine, rat

Overview

PACAP (6-38), amide, human, ovine, rat, is a highly effective antagonist of PACAP 38, demonstrating increased potency and selectivity compared to PACAP (6-27) in inhibiting PACAP-27 stimulated pituitary adenylate cyclase. This peptide’s performance is crucial for various research applications focusing on neurological pathways.

Key Features

• Highly potent antagonist of PACAP 38.
• More effective than PACAP (6-27) for enzyme inhibition.
• Ki values: 7nM for PACAP (6-38) vs. 150nM for PACAP (6-27).
• Applicable in diverse biological research settings.
• Available in various formats for convenience.

Specifications

FAQ

What is the primary use of PACAP (6-38)?

PACAP (6-38) is primarily used in research focusing on the inhibition of PACAP-27 stimulated pituitary adenylate cyclase, making it significant for studies in neurobiology and related fields.

How does PACAP (6-38) compare to PACAP (6-27)?

This peptide is much more potent and selective as an antagonist than PACAP (6-27), offering superior inhibition of specific enzymatic activity.

Where can I find other related peptides?

You can explore a range of related peptides in our Peptides category, including options like Autocamtide-2 and CREBtide.

Related Products

• PKG Substrate [RKRSRAE], Glasstide